nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—DHODH—malaria	0.594	1	CbGaD
Leflunomide—CYP2C9—Pyrimethamine—malaria	0.0344	0.131	CbGbCtD
Leflunomide—CYP2C9—Sulfadiazine—malaria	0.0344	0.131	CbGbCtD
Leflunomide—CYP1A2—Proguanil—malaria	0.0305	0.117	CbGbCtD
Leflunomide—CYP2C9—Artemether—malaria	0.0292	0.112	CbGbCtD
Leflunomide—CYP2C9—Proguanil—malaria	0.0275	0.105	CbGbCtD
Leflunomide—CYP1A2—Pentoxifylline—malaria	0.0219	0.0838	CbGbCtD
Leflunomide—CYP1A2—Quinine—malaria	0.0197	0.0752	CbGbCtD
Leflunomide—CYP2C9—Quinine—malaria	0.0177	0.0677	CbGbCtD
Leflunomide—CYP1A2—Quinidine—malaria	0.0173	0.0661	CbGbCtD
Leflunomide—CYP2C9—Quinidine—malaria	0.0156	0.0595	CbGbCtD
Leflunomide—CYP2C9—Dapsone—malaria	0.0134	0.0513	CbGbCtD
Leflunomide—PTK2B—blood plasma—malaria	0.0037	0.102	CbGeAlD
Leflunomide—DHODH—hematopoietic system—malaria	0.00323	0.0889	CbGeAlD
Leflunomide—DHODH—blood—malaria	0.00214	0.0589	CbGeAlD
Leflunomide—PTK2B—hematopoietic system—malaria	0.00205	0.0563	CbGeAlD
Leflunomide—AHR—saliva-secreting gland—malaria	0.00176	0.0485	CbGeAlD
Leflunomide—PTK2B—kidney—malaria	0.00168	0.0461	CbGeAlD
Leflunomide—DHODH—liver—malaria	0.00167	0.046	CbGeAlD
Leflunomide—PTK2B—digestive system—malaria	0.00142	0.0391	CbGeAlD
Leflunomide—PTK2B—blood—malaria	0.00135	0.0373	CbGeAlD
Leflunomide—DHODH—brain—malaria	0.00133	0.0365	CbGeAlD
Leflunomide—PTK2B—bone marrow—malaria	0.00131	0.0361	CbGeAlD
Leflunomide—AHR—digestive system—malaria	0.00117	0.0322	CbGeAlD
Leflunomide—CYP1A2—blood plasma—malaria	0.00114	0.0312	CbGeAlD
Leflunomide—AHR—blood—malaria	0.00111	0.0307	CbGeAlD
Leflunomide—AHR—bone marrow—malaria	0.00108	0.0297	CbGeAlD
Leflunomide—CYP2C9—blood plasma—malaria	0.00108	0.0297	CbGeAlD
Leflunomide—PTK2B—liver—malaria	0.00106	0.0292	CbGeAlD
Leflunomide—PTK2B—IL-2 Signaling Pathway—CISH—malaria	0.00102	0.0792	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000915	0.0714	CbGpPWpGaD
Leflunomide—AHR—liver—malaria	0.000871	0.024	CbGeAlD
Leflunomide—PTK2B—brain—malaria	0.000841	0.0231	CbGeAlD
Leflunomide—PTK2B—IL2-mediated signaling events—CISH—malaria	0.000831	0.0648	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000773	0.0603	CbGpPWpGaD
Leflunomide—AHR—brain—malaria	0.000691	0.019	CbGeAlD
Leflunomide—ABCG2—saliva-secreting gland—malaria	0.000683	0.0188	CbGeAlD
Leflunomide—CYP1A2—hematopoietic system—malaria	0.000628	0.0173	CbGeAlD
Leflunomide—CYP2C9—hematopoietic system—malaria	0.000596	0.0164	CbGeAlD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—CD36—malaria	0.000527	0.0411	CbGpPWpGaD
Leflunomide—CYP1A2—digestive system—malaria	0.000436	0.012	CbGeAlD
Leflunomide—ABCG2—blood—malaria	0.000432	0.0119	CbGeAlD
Leflunomide—ABCG2—bone marrow—malaria	0.000418	0.0115	CbGeAlD
Leflunomide—CYP1A2—blood—malaria	0.000416	0.0114	CbGeAlD
Leflunomide—CYP2C9—digestive system—malaria	0.000414	0.0114	CbGeAlD
Leflunomide—CYP2C9—blood—malaria	0.000395	0.0109	CbGeAlD
Leflunomide—ABCG2—liver—malaria	0.000338	0.0093	CbGeAlD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000333	0.0259	CbGpPWpGaD
Leflunomide—CYP1A2—liver—malaria	0.000325	0.00895	CbGeAlD
Leflunomide—CYP2C9—liver—malaria	0.000309	0.0085	CbGeAlD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000297	0.0231	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000295	0.023	CbGpPWpGaD
Leflunomide—ABCG2—Fluoropyrimidine Activity—DHFR—malaria	0.000283	0.022	CbGpPWpGaD
Leflunomide—ABCG2—brain—malaria	0.000268	0.00738	CbGeAlD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—CISH—malaria	0.000223	0.0174	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—FAS—malaria	0.000221	0.0172	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—TNF—malaria	0.000215	0.0168	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000215	0.0168	CbGpPWpGaD
Leflunomide—Eye disorder—Quinine—malaria	0.000195	0.00204	CcSEcCtD
Leflunomide—Eye disorder—Quinidine—malaria	0.000195	0.00204	CcSEcCtD
Leflunomide—PTK2B—Integrins in angiogenesis—KDR—malaria	0.000195	0.0152	CbGpPWpGaD
Leflunomide—Vomiting—Proguanil—malaria	0.000194	0.00203	CcSEcCtD
Leflunomide—Cardiac disorder—Quinine—malaria	0.000193	0.00203	CcSEcCtD
Leflunomide—Cardiac disorder—Quinidine—malaria	0.000193	0.00203	CcSEcCtD
Leflunomide—Anorexia—Sulfadiazine—malaria	0.000193	0.00202	CcSEcCtD
Leflunomide—Rash—Proguanil—malaria	0.000193	0.00202	CcSEcCtD
Leflunomide—Dermatitis—Proguanil—malaria	0.000192	0.00202	CcSEcCtD
Leflunomide—Headache—Proguanil—malaria	0.000191	0.002	CcSEcCtD
Leflunomide—Haemoglobin—Quinidine barbiturate—malaria	0.000189	0.00198	CcSEcCtD
Leflunomide—Haemoglobin—Pentoxifylline—malaria	0.000189	0.00198	CcSEcCtD
Leflunomide—Immune system disorder—Quinine—malaria	0.000188	0.00197	CcSEcCtD
Leflunomide—Immune system disorder—Quinidine—malaria	0.000188	0.00197	CcSEcCtD
Leflunomide—Haemorrhage—Quinidine barbiturate—malaria	0.000188	0.00197	CcSEcCtD
Leflunomide—Hepatitis—Quinidine barbiturate—malaria	0.000188	0.00197	CcSEcCtD
Leflunomide—Mediastinal disorder—Quinidine—malaria	0.000188	0.00197	CcSEcCtD
Leflunomide—Mediastinal disorder—Quinine—malaria	0.000188	0.00197	CcSEcCtD
Leflunomide—Haemorrhage—Pentoxifylline—malaria	0.000188	0.00197	CcSEcCtD
Leflunomide—Hepatitis—Pentoxifylline—malaria	0.000188	0.00197	CcSEcCtD
Leflunomide—Chills—Quinine—malaria	0.000187	0.00196	CcSEcCtD
Leflunomide—Chills—Quinidine—malaria	0.000187	0.00196	CcSEcCtD
Leflunomide—Urinary tract disorder—Quinidine barbiturate—malaria	0.000186	0.00195	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000185	0.00193	CcSEcCtD
Leflunomide—Urethral disorder—Quinidine barbiturate—malaria	0.000184	0.00193	CcSEcCtD
Leflunomide—Insomnia—Sulfadiazine—malaria	0.000183	0.00192	CcSEcCtD
Leflunomide—PTK2B—Signaling events mediated by VEGFR1 and VEGFR2—KDR—malaria	0.000183	0.0143	CbGpPWpGaD
Leflunomide—Mental disorder—Quinine—malaria	0.000183	0.00191	CcSEcCtD
Leflunomide—Mental disorder—Quinidine—malaria	0.000183	0.00191	CcSEcCtD
Leflunomide—Flatulence—Clindamycin—malaria	0.000182	0.00191	CcSEcCtD
Leflunomide—Malnutrition—Quinidine—malaria	0.000181	0.0019	CcSEcCtD
Leflunomide—Malnutrition—Quinine—malaria	0.000181	0.0019	CcSEcCtD
Leflunomide—Nausea—Proguanil—malaria	0.000181	0.0019	CcSEcCtD
Leflunomide—Dysgeusia—Clindamycin—malaria	0.000181	0.0019	CcSEcCtD
Leflunomide—Vision blurred—Dapsone—malaria	0.00018	0.00189	CcSEcCtD
Leflunomide—PTK2B—TCR Signaling Pathway—CD8A—malaria	0.000179	0.014	CbGpPWpGaD
Leflunomide—Back pain—Clindamycin—malaria	0.000179	0.00187	CcSEcCtD
Leflunomide—Erythema multiforme—Quinidine barbiturate—malaria	0.000178	0.00186	CcSEcCtD
Leflunomide—Muscle spasms—Clindamycin—malaria	0.000178	0.00186	CcSEcCtD
Leflunomide—Decreased appetite—Sulfadiazine—malaria	0.000176	0.00185	CcSEcCtD
Leflunomide—Eye disorder—Quinidine barbiturate—malaria	0.000176	0.00184	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Sulfadiazine—malaria	0.000175	0.00183	CcSEcCtD
Leflunomide—Cardiac disorder—Quinidine barbiturate—malaria	0.000175	0.00183	CcSEcCtD
Leflunomide—PTK2B—IL-2 Signaling Pathway—IL2—malaria	0.000174	0.0136	CbGpPWpGaD
Leflunomide—Vertigo—Dapsone—malaria	0.000172	0.0018	CcSEcCtD
Leflunomide—Vision blurred—Quinine—malaria	0.000171	0.00179	CcSEcCtD
Leflunomide—Vision blurred—Quinidine—malaria	0.000171	0.00179	CcSEcCtD
Leflunomide—Anaemia—Clindamycin—malaria	0.000171	0.00179	CcSEcCtD
Leflunomide—Immune system disorder—Quinidine barbiturate—malaria	0.00017	0.00178	CcSEcCtD
Leflunomide—Immune system disorder—Pentoxifylline—malaria	0.00017	0.00178	CcSEcCtD
Leflunomide—Mediastinal disorder—Quinidine barbiturate—malaria	0.00017	0.00178	CcSEcCtD
Leflunomide—Chills—Quinidine barbiturate—malaria	0.000169	0.00177	CcSEcCtD
Leflunomide—Arrhythmia—Pentoxifylline—malaria	0.000168	0.00176	CcSEcCtD
Leflunomide—DHODH—Metabolism—SLC4A1—malaria	0.000167	0.013	CbGpPWpGaD
Leflunomide—Cough—Dapsone—malaria	0.000167	0.00175	CcSEcCtD
Leflunomide—Vertigo—Clindamycin—malaria	0.000166	0.00174	CcSEcCtD
Leflunomide—Angioedema—Quinine—malaria	0.000166	0.00174	CcSEcCtD
Leflunomide—Angioedema—Quinidine—malaria	0.000166	0.00174	CcSEcCtD
Leflunomide—Gastrointestinal pain—Sulfadiazine—malaria	0.000166	0.00174	CcSEcCtD
Leflunomide—Leukopenia—Clindamycin—malaria	0.000166	0.00173	CcSEcCtD
Leflunomide—Mental disorder—Quinidine barbiturate—malaria	0.000165	0.00173	CcSEcCtD
Leflunomide—Malnutrition—Quinidine barbiturate—malaria	0.000164	0.00172	CcSEcCtD
Leflunomide—Vertigo—Quinidine—malaria	0.000163	0.00171	CcSEcCtD
Leflunomide—Vertigo—Quinine—malaria	0.000163	0.00171	CcSEcCtD
Leflunomide—PTK2B—TCR Signaling Pathway—FAS—malaria	0.000163	0.0127	CbGpPWpGaD
Leflunomide—Leukopenia—Quinidine—malaria	0.000162	0.0017	CcSEcCtD
Leflunomide—Leukopenia—Quinine—malaria	0.000162	0.0017	CcSEcCtD
Leflunomide—Flatulence—Pentoxifylline—malaria	0.000161	0.00169	CcSEcCtD
Leflunomide—Urticaria—Sulfadiazine—malaria	0.000161	0.00169	CcSEcCtD
Leflunomide—PTK2B—IL2-mediated signaling events—IFNG—malaria	0.000161	0.0125	CbGpPWpGaD
Leflunomide—Palpitations—Quinine—malaria	0.00016	0.00168	CcSEcCtD
Leflunomide—Palpitations—Quinidine—malaria	0.00016	0.00168	CcSEcCtD
Leflunomide—Abdominal pain—Sulfadiazine—malaria	0.00016	0.00168	CcSEcCtD
Leflunomide—Body temperature increased—Sulfadiazine—malaria	0.00016	0.00168	CcSEcCtD
Leflunomide—Dysgeusia—Pentoxifylline—malaria	0.00016	0.00168	CcSEcCtD
Leflunomide—Hypertension—Clindamycin—malaria	0.00016	0.00167	CcSEcCtD
Leflunomide—PTK2B—Interleukin-2 signaling—IL2—malaria	0.000159	0.0124	CbGpPWpGaD
Leflunomide—Back pain—Pentoxifylline—malaria	0.000158	0.00166	CcSEcCtD
Leflunomide—PTK2B—Signaling by Interleukins—IL18—malaria	0.000157	0.0123	CbGpPWpGaD
Leflunomide—Muscle spasms—Pentoxifylline—malaria	0.000157	0.00165	CcSEcCtD
Leflunomide—DHODH—Metabolism—DECR1—malaria	0.000157	0.0122	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—FAS—malaria	0.000156	0.0121	CbGpPWpGaD
Leflunomide—Discomfort—Clindamycin—malaria	0.000156	0.00163	CcSEcCtD
Leflunomide—Chest pain—Quinine—malaria	0.000154	0.00162	CcSEcCtD
Leflunomide—Myalgia—Quinine—malaria	0.000154	0.00162	CcSEcCtD
Leflunomide—Myalgia—Quinidine—malaria	0.000154	0.00162	CcSEcCtD
Leflunomide—Chest pain—Quinidine—malaria	0.000154	0.00162	CcSEcCtD
Leflunomide—Vision blurred—Quinidine barbiturate—malaria	0.000154	0.00162	CcSEcCtD
Leflunomide—Vision blurred—Pentoxifylline—malaria	0.000154	0.00161	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000153	0.00161	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000153	0.00161	CcSEcCtD
Leflunomide—Tachycardia—Dapsone—malaria	0.000152	0.0016	CcSEcCtD
Leflunomide—Ill-defined disorder—Pentoxifylline—malaria	0.000152	0.00159	CcSEcCtD
Leflunomide—Anaemia—Pentoxifylline—malaria	0.000151	0.00158	CcSEcCtD
Leflunomide—Anaphylactic shock—Clindamycin—malaria	0.000151	0.00158	CcSEcCtD
Leflunomide—Angioedema—Quinidine barbiturate—malaria	0.00015	0.00157	CcSEcCtD
Leflunomide—Angioedema—Pentoxifylline—malaria	0.000149	0.00156	CcSEcCtD
Leflunomide—Hypersensitivity—Sulfadiazine—malaria	0.000149	0.00156	CcSEcCtD
Leflunomide—ABCG2—HIF-2-alpha transcription factor network—KDR—malaria	0.000148	0.0115	CbGpPWpGaD
Leflunomide—Thrombocytopenia—Clindamycin—malaria	0.000148	0.00155	CcSEcCtD
Leflunomide—Malaise—Pentoxifylline—malaria	0.000147	0.00154	CcSEcCtD
Leflunomide—Vertigo—Quinidine barbiturate—malaria	0.000147	0.00154	CcSEcCtD
Leflunomide—Leukopenia—Quinidine barbiturate—malaria	0.000147	0.00154	CcSEcCtD
Leflunomide—Leukopenia—Pentoxifylline—malaria	0.000146	0.00153	CcSEcCtD
Leflunomide—Nervous system disorder—Quinidine—malaria	0.000145	0.00152	CcSEcCtD
Leflunomide—Nervous system disorder—Quinine—malaria	0.000145	0.00152	CcSEcCtD
Leflunomide—Thrombocytopenia—Quinine—malaria	0.000145	0.00152	CcSEcCtD
Leflunomide—Thrombocytopenia—Quinidine—malaria	0.000145	0.00152	CcSEcCtD
Leflunomide—Palpitations—Quinidine barbiturate—malaria	0.000145	0.00152	CcSEcCtD
Leflunomide—Tachycardia—Quinine—malaria	0.000145	0.00151	CcSEcCtD
Leflunomide—Tachycardia—Quinidine—malaria	0.000145	0.00151	CcSEcCtD
Leflunomide—Palpitations—Pentoxifylline—malaria	0.000144	0.00151	CcSEcCtD
Leflunomide—Skin disorder—Quinine—malaria	0.000144	0.00151	CcSEcCtD
Leflunomide—Skin disorder—Quinidine—malaria	0.000144	0.00151	CcSEcCtD
Leflunomide—Pruritus—Sulfadiazine—malaria	0.000143	0.0015	CcSEcCtD
Leflunomide—Hyperhidrosis—Quinine—malaria	0.000143	0.0015	CcSEcCtD
Leflunomide—Hyperhidrosis—Quinidine—malaria	0.000143	0.0015	CcSEcCtD
Leflunomide—PTK2B—IL2-mediated signaling events—IL2—malaria	0.000143	0.0111	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—HBB—malaria	0.000142	0.0111	CbGpPWpGaD
Leflunomide—Anorexia—Quinine—malaria	0.000141	0.00148	CcSEcCtD
Leflunomide—Anorexia—Quinidine—malaria	0.000141	0.00148	CcSEcCtD
Leflunomide—Insomnia—Dapsone—malaria	0.000141	0.00148	CcSEcCtD
Leflunomide—Hypertension—Pentoxifylline—malaria	0.000141	0.00148	CcSEcCtD
Leflunomide—Hypotension—Clindamycin—malaria	0.000141	0.00148	CcSEcCtD
Leflunomide—Arthralgia—Quinidine barbiturate—malaria	0.000139	0.00146	CcSEcCtD
Leflunomide—Chest pain—Quinidine barbiturate—malaria	0.000139	0.00146	CcSEcCtD
Leflunomide—Myalgia—Quinidine barbiturate—malaria	0.000139	0.00146	CcSEcCtD
Leflunomide—Myalgia—Pentoxifylline—malaria	0.000139	0.00146	CcSEcCtD
Leflunomide—Chest pain—Pentoxifylline—malaria	0.000139	0.00146	CcSEcCtD
Leflunomide—Anxiety—Quinidine barbiturate—malaria	0.000139	0.00146	CcSEcCtD
Leflunomide—Diarrhoea—Sulfadiazine—malaria	0.000139	0.00145	CcSEcCtD
Leflunomide—Anxiety—Pentoxifylline—malaria	0.000139	0.00145	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000138	0.00145	CcSEcCtD
Leflunomide—Hypotension—Quinine—malaria	0.000138	0.00145	CcSEcCtD
Leflunomide—Hypotension—Quinidine—malaria	0.000138	0.00145	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000138	0.00145	CcSEcCtD
Leflunomide—Discomfort—Pentoxifylline—malaria	0.000138	0.00144	CcSEcCtD
Leflunomide—Dry mouth—Pentoxifylline—malaria	0.000136	0.00143	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Quinidine—malaria	0.000135	0.00141	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Quinine—malaria	0.000135	0.00141	CcSEcCtD
Leflunomide—Dyspnoea—Clindamycin—malaria	0.000135	0.00141	CcSEcCtD
Leflunomide—Anaphylactic shock—Pentoxifylline—malaria	0.000133	0.0014	CcSEcCtD
Leflunomide—AHR—Circadian rythm related genes—NOS2—malaria	0.000133	0.0104	CbGpPWpGaD
Leflunomide—Dyspepsia—Clindamycin—malaria	0.000133	0.00139	CcSEcCtD
Leflunomide—Infection—Pentoxifylline—malaria	0.000133	0.00139	CcSEcCtD
Leflunomide—Dyspnoea—Quinidine—malaria	0.000132	0.00138	CcSEcCtD
Leflunomide—Dyspnoea—Quinine—malaria	0.000132	0.00138	CcSEcCtD
Leflunomide—Nervous system disorder—Quinidine barbiturate—malaria	0.000131	0.00137	CcSEcCtD
Leflunomide—Thrombocytopenia—Quinidine barbiturate—malaria	0.000131	0.00137	CcSEcCtD
Leflunomide—Thrombocytopenia—Pentoxifylline—malaria	0.000131	0.00137	CcSEcCtD
Leflunomide—Tachycardia—Quinidine barbiturate—malaria	0.00013	0.00137	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Clindamycin—malaria	0.00013	0.00137	CcSEcCtD
Leflunomide—Tachycardia—Pentoxifylline—malaria	0.00013	0.00136	CcSEcCtD
Leflunomide—Fatigue—Clindamycin—malaria	0.00013	0.00136	CcSEcCtD
Leflunomide—Skin disorder—Quinidine barbiturate—malaria	0.00013	0.00136	CcSEcCtD
Leflunomide—Skin disorder—Pentoxifylline—malaria	0.00013	0.00136	CcSEcCtD
Leflunomide—Hyperhidrosis—Quinidine barbiturate—malaria	0.000129	0.00135	CcSEcCtD
Leflunomide—Pain—Clindamycin—malaria	0.000129	0.00135	CcSEcCtD
Leflunomide—Constipation—Clindamycin—malaria	0.000129	0.00135	CcSEcCtD
Leflunomide—Hyperhidrosis—Pentoxifylline—malaria	0.000129	0.00135	CcSEcCtD
Leflunomide—Vomiting—Sulfadiazine—malaria	0.000129	0.00135	CcSEcCtD
Leflunomide—Decreased appetite—Quinidine—malaria	0.000129	0.00135	CcSEcCtD
Leflunomide—Decreased appetite—Quinine—malaria	0.000129	0.00135	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Quinine—malaria	0.000128	0.00134	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Quinidine—malaria	0.000128	0.00134	CcSEcCtD
Leflunomide—Rash—Sulfadiazine—malaria	0.000128	0.00134	CcSEcCtD
Leflunomide—Dermatitis—Sulfadiazine—malaria	0.000128	0.00134	CcSEcCtD
Leflunomide—Gastrointestinal pain—Dapsone—malaria	0.000128	0.00134	CcSEcCtD
Leflunomide—Anorexia—Quinidine barbiturate—malaria	0.000127	0.00133	CcSEcCtD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—KDR—malaria	0.000127	0.00993	CbGpPWpGaD
Leflunomide—Anorexia—Pentoxifylline—malaria	0.000127	0.00133	CcSEcCtD
Leflunomide—Headache—Sulfadiazine—malaria	0.000127	0.00133	CcSEcCtD
Leflunomide—DHODH—Metabolism—PKLR—malaria	0.000126	0.00986	CbGpPWpGaD
Leflunomide—Hypotension—Quinidine barbiturate—malaria	0.000125	0.00131	CcSEcCtD
Leflunomide—Hypotension—Pentoxifylline—malaria	0.000125	0.00131	CcSEcCtD
Leflunomide—Gastrointestinal pain—Clindamycin—malaria	0.000123	0.00129	CcSEcCtD
Leflunomide—Abdominal pain—Dapsone—malaria	0.000123	0.00129	CcSEcCtD
Leflunomide—Body temperature increased—Dapsone—malaria	0.000123	0.00129	CcSEcCtD
Leflunomide—Feeling abnormal—Quinidine—malaria	0.000122	0.00128	CcSEcCtD
Leflunomide—Feeling abnormal—Quinine—malaria	0.000122	0.00128	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000122	0.00128	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000122	0.00127	CcSEcCtD
Leflunomide—Gastrointestinal pain—Quinidine—malaria	0.000121	0.00127	CcSEcCtD
Leflunomide—Gastrointestinal pain—Quinine—malaria	0.000121	0.00127	CcSEcCtD
Leflunomide—Insomnia—Pentoxifylline—malaria	0.000121	0.00126	CcSEcCtD
Leflunomide—Nausea—Sulfadiazine—malaria	0.00012	0.00126	CcSEcCtD
Leflunomide—PTK2B—Signaling by VEGF—KDR—malaria	0.00012	0.00937	CbGpPWpGaD
Leflunomide—Urticaria—Clindamycin—malaria	0.00012	0.00126	CcSEcCtD
Leflunomide—Body temperature increased—Clindamycin—malaria	0.000119	0.00125	CcSEcCtD
Leflunomide—Abdominal pain—Clindamycin—malaria	0.000119	0.00125	CcSEcCtD
Leflunomide—Dyspnoea—Quinidine barbiturate—malaria	0.000119	0.00125	CcSEcCtD
Leflunomide—Dyspnoea—Pentoxifylline—malaria	0.000119	0.00125	CcSEcCtD
Leflunomide—Urticaria—Quinidine—malaria	0.000118	0.00123	CcSEcCtD
Leflunomide—Urticaria—Quinine—malaria	0.000118	0.00123	CcSEcCtD
Leflunomide—Dyspepsia—Pentoxifylline—malaria	0.000117	0.00123	CcSEcCtD
Leflunomide—Abdominal pain—Quinine—malaria	0.000117	0.00123	CcSEcCtD
Leflunomide—Abdominal pain—Quinidine—malaria	0.000117	0.00123	CcSEcCtD
Leflunomide—Body temperature increased—Quinidine—malaria	0.000117	0.00123	CcSEcCtD
Leflunomide—Body temperature increased—Quinine—malaria	0.000117	0.00123	CcSEcCtD
Leflunomide—Decreased appetite—Quinidine barbiturate—malaria	0.000116	0.00122	CcSEcCtD
Leflunomide—Decreased appetite—Pentoxifylline—malaria	0.000116	0.00121	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000115	0.00121	CcSEcCtD
Leflunomide—Constipation—Quinidine barbiturate—malaria	0.000114	0.0012	CcSEcCtD
Leflunomide—Pain—Quinidine barbiturate—malaria	0.000114	0.0012	CcSEcCtD
Leflunomide—Constipation—Pentoxifylline—malaria	0.000114	0.0012	CcSEcCtD
Leflunomide—DHODH—Metabolism—G6PD—malaria	0.000113	0.00879	CbGpPWpGaD
Leflunomide—Hypersensitivity—Clindamycin—malaria	0.000111	0.00117	CcSEcCtD
Leflunomide—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	0.00011	0.0086	CbGpPWpGaD
Leflunomide—Feeling abnormal—Quinidine barbiturate—malaria	0.00011	0.00115	CcSEcCtD
Leflunomide—Feeling abnormal—Pentoxifylline—malaria	0.00011	0.00115	CcSEcCtD
Leflunomide—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000109	0.00114	CcSEcCtD
Leflunomide—Hypersensitivity—Quinine—malaria	0.000109	0.00114	CcSEcCtD
Leflunomide—Hypersensitivity—Quinidine—malaria	0.000109	0.00114	CcSEcCtD
Leflunomide—Gastrointestinal pain—Pentoxifylline—malaria	0.000109	0.00114	CcSEcCtD
Leflunomide—PTK2B—CXCR4-mediated signaling events—CD4—malaria	0.000109	0.00849	CbGpPWpGaD
Leflunomide—Asthenia—Clindamycin—malaria	0.000108	0.00113	CcSEcCtD
Leflunomide—Pruritus—Clindamycin—malaria	0.000107	0.00112	CcSEcCtD
Leflunomide—Asthenia—Quinidine—malaria	0.000106	0.00111	CcSEcCtD
Leflunomide—Asthenia—Quinine—malaria	0.000106	0.00111	CcSEcCtD
Leflunomide—Urticaria—Quinidine barbiturate—malaria	0.000106	0.00111	CcSEcCtD
Leflunomide—Urticaria—Pentoxifylline—malaria	0.000106	0.00111	CcSEcCtD
Leflunomide—Abdominal pain—Quinidine barbiturate—malaria	0.000106	0.00111	CcSEcCtD
Leflunomide—Body temperature increased—Quinidine barbiturate—malaria	0.000106	0.00111	CcSEcCtD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—malaria	0.000105	0.00822	CbGpPWpGaD
Leflunomide—Abdominal pain—Pentoxifylline—malaria	0.000105	0.0011	CcSEcCtD
Leflunomide—Body temperature increased—Pentoxifylline—malaria	0.000105	0.0011	CcSEcCtD
Leflunomide—Pruritus—Quinidine—malaria	0.000105	0.0011	CcSEcCtD
Leflunomide—Pruritus—Quinine—malaria	0.000105	0.0011	CcSEcCtD
Leflunomide—Diarrhoea—Clindamycin—malaria	0.000103	0.00108	CcSEcCtD
Leflunomide—PTK2B—TCR Signaling Pathway—CD4—malaria	0.000103	0.00803	CbGpPWpGaD
Leflunomide—Diarrhoea—Quinidine—malaria	0.000101	0.00106	CcSEcCtD
Leflunomide—Diarrhoea—Quinine—malaria	0.000101	0.00106	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000101	0.00786	CbGpPWpGaD
Leflunomide—Dizziness—Clindamycin—malaria	9.98e-05	0.00105	CcSEcCtD
Leflunomide—Vomiting—Dapsone—malaria	9.92e-05	0.00104	CcSEcCtD
Leflunomide—Hypersensitivity—Quinidine barbiturate—malaria	9.85e-05	0.00103	CcSEcCtD
Leflunomide—Hypersensitivity—Pentoxifylline—malaria	9.83e-05	0.00103	CcSEcCtD
Leflunomide—Dizziness—Quinine—malaria	9.79e-05	0.00103	CcSEcCtD
Leflunomide—Dizziness—Quinidine—malaria	9.79e-05	0.00103	CcSEcCtD
Leflunomide—Headache—Dapsone—malaria	9.78e-05	0.00102	CcSEcCtD
Leflunomide—Vomiting—Clindamycin—malaria	9.6e-05	0.00101	CcSEcCtD
Leflunomide—Asthenia—Quinidine barbiturate—malaria	9.59e-05	0.001	CcSEcCtD
Leflunomide—Asthenia—Pentoxifylline—malaria	9.57e-05	0.001	CcSEcCtD
Leflunomide—Rash—Clindamycin—malaria	9.52e-05	0.000997	CcSEcCtD
Leflunomide—PTK2B—TCR Signaling Pathway—IL1B—malaria	9.52e-05	0.00742	CbGpPWpGaD
Leflunomide—Dermatitis—Clindamycin—malaria	9.51e-05	0.000996	CcSEcCtD
Leflunomide—Headache—Clindamycin—malaria	9.46e-05	0.000991	CcSEcCtD
Leflunomide—Pruritus—Quinidine barbiturate—malaria	9.46e-05	0.000991	CcSEcCtD
Leflunomide—Pruritus—Pentoxifylline—malaria	9.44e-05	0.000989	CcSEcCtD
Leflunomide—CYP1A2—Arachidonic acid metabolism—HPGDS—malaria	9.43e-05	0.00735	CbGpPWpGaD
Leflunomide—Vomiting—Quinine—malaria	9.42e-05	0.000986	CcSEcCtD
Leflunomide—Vomiting—Quinidine—malaria	9.42e-05	0.000986	CcSEcCtD
Leflunomide—AHR—Adipogenesis—TNF—malaria	9.37e-05	0.00731	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL6—malaria	9.37e-05	0.00731	CbGpPWpGaD
Leflunomide—Rash—Quinidine—malaria	9.34e-05	0.000978	CcSEcCtD
Leflunomide—Rash—Quinine—malaria	9.34e-05	0.000978	CcSEcCtD
Leflunomide—Dermatitis—Quinine—malaria	9.33e-05	0.000977	CcSEcCtD
Leflunomide—Dermatitis—Quinidine—malaria	9.33e-05	0.000977	CcSEcCtD
Leflunomide—Headache—Quinidine—malaria	9.28e-05	0.000972	CcSEcCtD
Leflunomide—Headache—Quinine—malaria	9.28e-05	0.000972	CcSEcCtD
Leflunomide—Nausea—Dapsone—malaria	9.27e-05	0.000971	CcSEcCtD
Leflunomide—Diarrhoea—Quinidine barbiturate—malaria	9.14e-05	0.000958	CcSEcCtD
Leflunomide—Diarrhoea—Pentoxifylline—malaria	9.13e-05	0.000956	CcSEcCtD
Leflunomide—Nausea—Clindamycin—malaria	8.97e-05	0.000939	CcSEcCtD
Leflunomide—Dizziness—Quinidine barbiturate—malaria	8.84e-05	0.000926	CcSEcCtD
Leflunomide—Dizziness—Pentoxifylline—malaria	8.82e-05	0.000924	CcSEcCtD
Leflunomide—Nausea—Quinine—malaria	8.8e-05	0.000922	CcSEcCtD
Leflunomide—Nausea—Quinidine—malaria	8.8e-05	0.000922	CcSEcCtD
Leflunomide—DHODH—Metabolism—HPGDS—malaria	8.6e-05	0.0067	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	8.52e-05	0.00664	CbGpPWpGaD
Leflunomide—Vomiting—Quinidine barbiturate—malaria	8.5e-05	0.00089	CcSEcCtD
Leflunomide—Vomiting—Pentoxifylline—malaria	8.48e-05	0.000889	CcSEcCtD
Leflunomide—Rash—Quinidine barbiturate—malaria	8.43e-05	0.000883	CcSEcCtD
Leflunomide—Dermatitis—Quinidine barbiturate—malaria	8.42e-05	0.000882	CcSEcCtD
Leflunomide—Rash—Pentoxifylline—malaria	8.41e-05	0.000881	CcSEcCtD
Leflunomide—Dermatitis—Pentoxifylline—malaria	8.4e-05	0.00088	CcSEcCtD
Leflunomide—Headache—Quinidine barbiturate—malaria	8.37e-05	0.000877	CcSEcCtD
Leflunomide—Headache—Pentoxifylline—malaria	8.36e-05	0.000876	CcSEcCtD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—NOS2—malaria	8.29e-05	0.00646	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL1B—malaria	8.22e-05	0.00641	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL2—malaria	8.19e-05	0.00639	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—DHFR—malaria	7.97e-05	0.00622	CbGpPWpGaD
Leflunomide—Nausea—Quinidine barbiturate—malaria	7.94e-05	0.000832	CcSEcCtD
Leflunomide—Nausea—Pentoxifylline—malaria	7.92e-05	0.00083	CcSEcCtD
Leflunomide—DHODH—Metabolism—SCARB1—malaria	7.89e-05	0.00615	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—IL6—malaria	7.56e-05	0.0059	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL18—malaria	7.35e-05	0.00573	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CISH—malaria	7.27e-05	0.00567	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-B—malaria	6.96e-05	0.00543	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—FCGR2B—malaria	6.87e-05	0.00535	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TIRAP—malaria	6.12e-05	0.00477	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—HPGDS—malaria	6e-05	0.00468	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—CD36—malaria	5.81e-05	0.00453	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC4A1—malaria	5.76e-05	0.00449	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CR1—malaria	5.69e-05	0.00444	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—ICAM1—malaria	5.65e-05	0.00441	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL6—malaria	5.57e-05	0.00434	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—IL6—malaria	5.34e-05	0.00416	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CD36—malaria	4.95e-05	0.00386	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—IL6—malaria	4.85e-05	0.00378	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TLR9—malaria	4.84e-05	0.00377	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL6—malaria	4.82e-05	0.00375	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—IL6—malaria	4.58e-05	0.00357	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNG—malaria	4.3e-05	0.00335	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—HPGDS—malaria	4.11e-05	0.0032	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ACKR1—malaria	3.88e-05	0.00303	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—FCGR2A—malaria	3.87e-05	0.00302	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1B—malaria	3.84e-05	0.00299	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL2—malaria	3.82e-05	0.00298	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	3.66e-05	0.00286	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—HPGDS—malaria	3.51e-05	0.00274	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	3.27e-05	0.00255	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	3.25e-05	0.00254	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—DHODH—malaria	3.17e-05	0.00248	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TLR9—malaria	3.13e-05	0.00244	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	2.88e-05	0.00224	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SLC4A1—malaria	2.7e-05	0.0021	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—DECR1—malaria	2.54e-05	0.00198	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	2.46e-05	0.00192	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL18—malaria	2.4e-05	0.00187	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD40LG—malaria	2.39e-05	0.00186	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	2.37e-05	0.00185	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	2.37e-05	0.00185	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD8A—malaria	2.36e-05	0.00184	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HBB—malaria	2.3e-05	0.00179	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-B—malaria	2.27e-05	0.00177	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—malaria	2.25e-05	0.00175	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD36—malaria	2.23e-05	0.00174	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PKLR—malaria	2.05e-05	0.00159	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CRP—malaria	2.01e-05	0.00157	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TLR4—malaria	1.93e-05	0.0015	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ICAM1—malaria	1.85e-05	0.00144	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—G6PD—malaria	1.82e-05	0.00142	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DHODH—malaria	1.6e-05	0.00125	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.58e-05	0.00123	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.45e-05	0.00113	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNG—malaria	1.41e-05	0.0011	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HPGDS—malaria	1.39e-05	0.00108	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DHODH—malaria	1.37e-05	0.00107	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC4A1—malaria	1.36e-05	0.00106	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD4—malaria	1.36e-05	0.00106	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.35e-05	0.00105	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—DHFR—malaria	1.29e-05	0.00101	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DECR1—malaria	1.28e-05	0.000999	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SCARB1—malaria	1.28e-05	0.000995	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1B—malaria	1.25e-05	0.000977	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL2—malaria	1.25e-05	0.000974	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—KDR—malaria	1.25e-05	0.000971	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.24e-05	0.000965	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC4A1—malaria	1.17e-05	0.000908	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HBB—malaria	1.16e-05	0.000904	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DECR1—malaria	1.1e-05	0.000854	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PKLR—malaria	1.03e-05	0.000806	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HBB—malaria	9.91e-06	0.000772	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—G6PD—malaria	9.21e-06	0.000718	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	9.09e-06	0.000708	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PKLR—malaria	8.83e-06	0.000688	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL2—malaria	8.07e-06	0.00063	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CD36—malaria	8.01e-06	0.000625	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—G6PD—malaria	7.87e-06	0.000614	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	7.77e-06	0.000605	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—malaria	7.34e-06	0.000572	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HPGDS—malaria	7.02e-06	0.000548	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DHFR—malaria	6.52e-06	0.000508	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SCARB1—malaria	6.45e-06	0.000503	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HPGDS—malaria	6e-06	0.000468	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DHFR—malaria	5.57e-06	0.000434	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SCARB1—malaria	5.51e-06	0.00043	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—malaria	4.75e-06	0.00037	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CD36—malaria	4.05e-06	0.000316	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CD36—malaria	3.46e-06	0.00027	CbGpPWpGaD
